Today: 20 May 2026

Morgan Stanley stock rebounds after Thursday slide as CPI cools; Fed minutes, Basel rules loom

Morgan Stanley stock rebounds after Thursday slide as CPI cools; Fed minutes, Basel rules loom

Morgan Stanley shares closed up 1.8% at $171.15 Friday, rebounding after a 4.9% drop Thursday. U.S. inflation data came in cooler than expected, easing rate concerns and lifting stocks. Investors remain cautious ahead of Fed minutes Feb. 18 and possible new big-bank capital rules. Morgan Stanley declared dividends on several preferred stock series.
Boeing stock: BA shares rise Friday — what investors watch next after FAA and defense headlines

Boeing stock: BA shares rise Friday — what investors watch next after FAA and defense headlines

Boeing shares rose 1.5% to $242.96 Friday as the FAA proposed new inspections for older 737s after cracks were found in fuselage skin. The U.S. Air Force awarded Boeing a sole-source contract for GBU-57 bunker-buster bombs worth over $100 million. India approved a $40 billion military upgrade including Boeing P-8I aircraft. Boeing cited a 60% drop in Spirit AeroSystems defects since tightening inspections.
Chevron stock price closes higher as Venezuela sanctions ease; traders eye OPEC+ and Tuesday’s reopen

Chevron stock price closes higher as Venezuela sanctions ease; traders eye OPEC+ and Tuesday’s reopen

Chevron shares closed up 0.73% at $183.74 on Friday after U.S. authorities eased sanctions on Venezuela’s energy sector. The move allows companies like Chevron to keep operating and pursue new investment talks. Oil prices ended slightly higher, with Brent at $67.75 a barrel. OPEC+ producers are set to meet March 1 to discuss possible output increases.
14 February 2026
Bank of America stock price steadies near $52 after choppy week — what to watch next

Bank of America stock price steadies near $52 after choppy week — what to watch next

Bank of America shares closed Friday nearly flat at $52.55 after a 2.5% drop Thursday, with 31.4 million shares traded. CEO Brian Moynihan’s 2025 pay rose over 17% to $41 million. A federal judge allowed a Jeffrey Epstein-related class action to proceed, with trial set for May 11. U.S. markets are closed Monday for a holiday; Fed minutes and inflation data are due next week.
14 February 2026
Qualcomm stock price: QCOM ends higher, but Samsung launch and memory crunch loom into next week

Qualcomm stock price: QCOM ends higher, but Samsung launch and memory crunch loom into next week

Qualcomm shares closed Friday up 1.6% at $140.70, outperforming the Nasdaq as Nvidia and Broadcom fell. Trading volume topped 13 million shares, above the 50-day average, but the stock remains 32% below its 52-week high. U.S. markets are closed Monday for Washington’s Birthday, with trading set to resume Tuesday. Samsung’s Feb. 25 Galaxy Unpacked event is the next major industry event for handset demand signals.
Nebius stock pops 9%: $7-$9B run-rate target and France data centre plan put NBIS in focus

Nebius stock pops 9%: $7-$9B run-rate target and France data centre plan put NBIS in focus

Nebius Group shares closed up 9.2% at $98.01 Friday after unveiling a 240MW data center plan in northern France and raising its 2026 revenue target to $7–9 billion. Fourth-quarter revenue surged to $227.7 million, but capital spending hit $2.1 billion and revenue missed analyst forecasts. U.S. markets are closed Monday for Presidents’ Day; trading resumes Tuesday.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Go toTop